Sodium-Glucose Cotransporter 2 Inhibitors and Cardiovascular Events Among Patients with Type 2 Diabetes and Low-to-Normal Body Mass Index: A Nationwide Cohort Study with Target Trial Emulation.
Mori Y, Komura T, Adomi M, Yagi R, Fukuma S, Kondo N, Yanagita M, Duru OK, Tuttle KR, Inoue K*.(2024) Sodium-Glucose Cotransporter 2 Inhibitors and Cardiovascular Events Among Patients with Type 2 Diabetes and Low-to-Normal Body Mass Index: A Nationwide Cohort Study with Target Trial Emulation. Cardiovascular Diabetology. 23(1):372.